Acute respiratory tract infection leads to procoagulant changes in human subjects.
作者信息
van Wissen M, Keller T T, van Gorp E C M, Gerdes V E A, Meijers J C M, van Doornum G J J, Büller H R, Brandjes D P M
出版信息
J Thromb Haemost. 2011 Jul;9(7):1432-4. doi: 10.1111/j.1538-7836.2011.04340.x.
Abstract
摘要
相似文献
1
Acute respiratory tract infection leads to procoagulant changes in human subjects.急性呼吸道感染会导致人体出现促凝血变化。
J Thromb Haemost. 2011 Jul;9(7):1432-4. doi: 10.1111/j.1538-7836.2011.04340.x.
2
3
4
Epistaxis. A clinical study with special reference to fibrinolysis.鼻出血。一项特别涉及纤维蛋白溶解的临床研究。
Acta Otolaryngol Suppl. 1974;317:1-73. doi: 10.3109/00016487409129566.
5
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.库欣病中的高凝状态与促凝因子水平升高和纤维蛋白溶解受损有关，但在药物治疗诱导的短期生化缓解后并不逆转。
J Clin Endocrinol Metab. 2012 Apr;97(4):1303-10. doi: 10.1210/jc.2011-2753. Epub 2012 Jan 25.
6
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.COVID-19 中的纤维蛋白溶解关闭：临床特征、分子机制和治疗意义。
J Am Coll Surg. 2021 Jun;232(6):995-1003. doi: 10.1016/j.jamcollsurg.2021.02.019. Epub 2021 Mar 22.
7
[Legg-Perthes-Calvé disease and disorders of hemostasis].[勒-佩-卡病与止血障碍]
Arch Pediatr. 2002 Feb;9(2):221-2. doi: 10.1016/s0929-693x(01)00735-7.
8
[Hemostasis in influenza and acute respiratory viral infections in the middle-aged and elderly].
Ter Arkh. 1990;62(7):98-102.
9
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism.影响急性肺栓塞循环促凝微粒水平的因素。
Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):394-403. doi: 10.1016/j.acvd.2010.06.005. Epub 2010 Aug 13.
10
Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016.丹麦 2010 至 2016 年因实验室确诊的呼吸道感染引发的急性心肌梗死和中风。
Euro Surveill. 2020 Apr;25(17). doi: 10.2807/1560-7917.ES.2020.25.17.1900199.
引用本文的文献
1
A practical guidance on the prevention and treatment of childhood respiratory syncytial virus infection in Kurdistan.库尔德斯坦地区儿童呼吸道合胞病毒感染防治实用指南
Front Pediatr. 2025 Mar 13;13:1551734. doi: 10.3389/fped.2025.1551734. eCollection 2025.
2
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.抑肽酶（II）：用于治疗 COVID-19 和其他病毒病的吸入式给药。
Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209.
3
Sex-specific differences in the clinical profile among psychiatric patients with pulmonary Embolism: a hospital-based retrospective study.精神科肺栓塞患者临床特征的性别差异：一项基于医院的回顾性研究。
BMC Pulm Med. 2024 Jun 27;24(1):304. doi: 10.1186/s12890-024-03122-6.
4
Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice.比伐卢定对呼吸道合胞病毒诱导的新生小鼠肺部感染具有抗病毒活性。
Acta Pharm. 2022 Apr 13;72(3):415-425. doi: 10.2478/acph-2022-0022. Print 2022 Sep 1.
5
Studying C-reactive protein and D-dimer levels in blood may prevent severe complications: A study in Bangladeshi COVID-19 patients.研究血液中的C反应蛋白和D-二聚体水平可能预防严重并发症：一项针对孟加拉国新冠肺炎患者的研究。
Front Genet. 2022 Dec 9;13:966595. doi: 10.3389/fgene.2022.966595. eCollection 2022.
6
A Systematic Review of Abdominal Imaging Findings in COVID-19 Patients.新型冠状病毒肺炎患者腹部影像表现的系统评价
Visc Med. 2021 Aug 26;26(6):1-12. doi: 10.1159/000518473.
7
COVID-19-associated papilledema secondary to cerebral venous thrombosis in a young patient.COVID-19 相关脑静脉血栓形成致年轻患者并发牵牛花综合征。
Indian J Ophthalmol. 2021 Mar;69(3):770-772. doi: 10.4103/ijo.IJO_2660_20.
8
Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.炎症和血液学标志物作为 COVID-19 感染严重结局的预测因子：系统评价和荟萃分析。
Am J Emerg Med. 2021 Mar;41:110-119. doi: 10.1016/j.ajem.2020.12.076. Epub 2020 Dec 30.
9
Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.病毒感染相关心血管疾病的免疫机制。
Front Immunol. 2020 Oct 22;11:570681. doi: 10.3389/fimmu.2020.570681. eCollection 2020.
10
The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.D-二聚体与 2019 年冠状病毒病（COVID-19）住院患者死亡率、重症监护病房（ICU）入住率或急性呼吸窘迫综合征（ARDS）的相关性：系统评价和荟萃分析。
Heart Lung. 2021 Jan-Feb;50(1):9-12. doi: 10.1016/j.hrtlng.2020.08.024. Epub 2020 Sep 18.
本文引用的文献
1
Recent respiratory infection predicts atherothrombotic stroke: case-control study in a Buenos Aires healthcare system.近期呼吸道感染预示动脉粥样硬化血栓形成性卒中：布宜诺斯艾利斯医疗系统中的病例对照研究。
Stroke. 2009 Jun;40(6):1986-90. doi: 10.1161/STROKEAHA.108.535559. Epub 2009 Apr 9.
2
Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences.呼吸道病原体在因首次喘息发作住院的婴儿中的作用及其对复发的影响。
Clin Microbiol Infect. 2008 Jul;14(7):677-84. doi: 10.1111/j.1469-0691.2008.02016.x.
3
Increased thrombin generation after acute versus chronic coronary disease as assessed by the thrombin generation test.通过凝血酶生成试验评估，急性冠状动脉疾病与慢性冠状动脉疾病相比，凝血酶生成增加。
Thromb Haemost. 2008 Feb;99(2):382-7. doi: 10.1160/TH07-07-0443.
4
Acute respiratory tract infections in elderly patients increase systemic levels of hemostatic proteins.老年患者的急性呼吸道感染会增加止血蛋白的全身水平。
J Thromb Haemost. 2007 Jul;5(7):1567-9. doi: 10.1111/j.1538-7836.2007.02580.x. Epub 2007 Apr 16.
5
Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1.对生成活化蛋白C能力降低且纤溶酶原激活物抑制剂1缺乏的小鼠流感诱导的凝血和纤维蛋白溶解的影响
Circ Res. 2006 Nov 24;99(11):1261-9. doi: 10.1161/01.RES.0000250834.29108.1a. Epub 2006 Oct 26.
6
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting.社区环境中急性感染后深静脉血栓形成和肺栓塞的风险。
Lancet. 2006 Apr 1;367(9516):1075-1079. doi: 10.1016/S0140-6736(06)68474-2.
7
Risk of myocardial infarction and stroke after acute infection or vaccination.急性感染或接种疫苗后发生心肌梗死和中风的风险。
N Engl J Med. 2004 Dec 16;351(25):2611-8. doi: 10.1056/NEJMoa041747.
8
The impact of the inflammatory response on coagulation.炎症反应对凝血的影响。
Thromb Res. 2004;114(5-6):321-7. doi: 10.1016/j.thromres.2004.06.028.
9
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes.急性冠状动脉综合征患者的循环内皮细胞、血管性血友病因子、白细胞介素-6与预后
Blood. 2005 Jan 15;105(2):526-32. doi: 10.1182/blood-2004-03-1106. Epub 2004 Sep 16.
10
Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.内皮细胞标志物与冠心病风险：心肌梗死前瞻性流行病学研究（PRIME）
Circulation. 2004 Mar 23;109(11):1343-8. doi: 10.1161/01.CIR.0000120705.55512.EC. Epub 2004 Mar 15.
Zotero 插件